Karen L. Smith

10.1k total citations · 1 hit paper
81 papers, 2.5k citations indexed

About

Karen L. Smith is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Karen L. Smith has authored 81 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Karen L. Smith's work include Breast Cancer Treatment Studies (15 papers), Cancer survivorship and care (14 papers) and HER2/EGFR in Cancer Research (12 papers). Karen L. Smith is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Cancer survivorship and care (14 papers) and HER2/EGFR in Cancer Research (12 papers). Karen L. Smith collaborates with scholars based in United States, South Africa and United Kingdom. Karen L. Smith's co-authors include Carl Lombard, Thinus F. Kruger, J. A. Van Zyl, Jacobus P. van der Merwe, F. S. H. Stander, Roelof Menkveld, Claudine Isaacs, Vered Stearns, Chau T. Dang and Roberta L. DeBiasi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Karen L. Smith

76 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sperm morphologic features as a prognostic factor in in vitro fertilization

1986 993 citations Thinus F. Kruger, Roelof Menkveld et al. Fertility and Sterility profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen L. Smith United States	21	1.1k	926	570	308	296	81	2.5k
J.S. Dungan United States	23	615 0.6×	681 0.7×	216 0.4×	425 1.4×	1.0k 3.4×	449	3.2k
Alexander Melamed United States	30	1.6k 1.5×	644 0.7×	763 1.3×	86 0.3×	464 1.6×	214	3.8k
G. Body France	31	738 0.7×	302 0.3×	664 1.2×	158 0.5×	312 1.1×	183	3.5k
Annekathryn Goodman United States	36	2.0k 1.9×	364 0.4×	1.1k 1.9×	252 0.8×	258 0.9×	193	4.4k
Laurel W. Rice United States	38	1.9k 1.8×	433 0.5×	895 1.6×	436 1.4×	202 0.7×	122	4.5k
Mojgan Karimi‐Zarchi Iran	23	505 0.5×	397 0.4×	423 0.7×	83 0.3×	251 0.8×	138	1.9k
Muhieddine Seoud Lebanon	25	301 0.3×	376 0.4×	643 1.1×	283 0.9×	615 2.1×	103	2.4k
Vito Chiàntera Italy	41	3.6k 3.4×	673 0.7×	947 1.7×	183 0.6×	231 0.8×	323	6.1k
Emily Ko United States	24	798 0.7×	196 0.2×	669 1.2×	74 0.2×	119 0.4×	186	2.1k
Olivier Graesslin France	24	818 0.8×	364 0.4×	288 0.5×	86 0.3×	267 0.9×	159	2.1k

Countries citing papers authored by Karen L. Smith

Since Specialization

Citations

This map shows the geographic impact of Karen L. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen L. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen L. Smith more than expected).

Fields of papers citing papers by Karen L. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen L. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen L. Smith. The network helps show where Karen L. Smith may publish in the future.

Co-authorship network of co-authors of Karen L. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Karen L. Smith. A scholar is included among the top collaborators of Karen L. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen L. Smith. Karen L. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gersch, Christina L., N. Lynn Henry, Karen L. Smith, et al.. (2024). Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms. Pharmacogenetics and Genomics. 34(4). 126–129. 1 indexed citations

Smith, Karen L., et al.. (2023). Developmental activities of elite junior hockey players: an analysis of early sport specialization. Frontiers in Sports and Active Living. 5. 1253007–1253007. 1 indexed citations

Smith, Karen L., Hua‐Ling Tsai, David Lim, et al.. (2023). Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App. JCO Oncology Practice. 19(11). 981–989. 7 indexed citations

Blackford, Amanda L., et al.. (2022). Factors associated with worsening sexual function during adjuvant endocrine therapy in a prospective clinic-based cohort of women with early-stage breast cancer. Breast Cancer Research and Treatment. 196(3). 535–547. 3 indexed citations

Connolly, Roisín M., Fengmin Zhao, Kathy D. Miller, et al.. (2021). E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor–Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group. Journal of Clinical Oncology. 39(28). 3171–3181. 76 indexed citations

Khoury, Katia, Filipa Lynce, Ana Barac, et al.. (2021). Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function. Breast Cancer Research and Treatment. 185(3). 863–868. 20 indexed citations

Walsh, Elaine M., John H. Fetting, Deborah K. Armstrong, et al.. (2021). Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes. Clinical Breast Cancer. 22(4). 319–325. 8 indexed citations

O’Sullivan, Ciara C., Sheeba Irshad, Zheyu Wang, et al.. (2020). Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period. Breast Cancer Research and Treatment. 180(3). 695–706. 18 indexed citations

Walsh, Elaine M., Karen L. Smith, & Vered Stearns. (2020). Management of hormone receptor-positive, HER2-negative early breast cancer. Seminars in Oncology. 47(4). 187–200. 34 indexed citations

10.

Bowen, Deborah J., Eileen H. Shinn, Gretchen Kimmick, et al.. (2019). Patient‐reported outcomes in the Translational Breast Cancer Research Consortium. Cancer. 126(5). 922–930. 5 indexed citations

11.

Smith, Karen L., et al.. (2018). Advances in Fertility Preservation for Young Women With Cancer. American Society of Clinical Oncology Educational Book. 38(38). 27–37. 17 indexed citations

12.

Florido, Roberta, et al.. (2017). Cardiotoxicity From Human Epidermal Growth Factor Receptor‐2 (HER2) Targeted Therapies. Journal of the American Heart Association. 6(9). 63 indexed citations

13.

Lynce, Filipa, Ana Barac, Ming Tan, et al.. (2017). SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. The Oncologist. 22(5). 518–525. 28 indexed citations

14.

Mackay, William G., et al.. (2014). A review of infection control in community healthcare: new challenges but old foes. European Journal of Clinical Microbiology & Infectious Diseases. 33(12). 2121–2130. 2 indexed citations

15.

Sullivan, Patrick W., Karen L. Smith, Vahram Ghushchyan, et al.. (2013). Asthma in USA: its impact on health-related quality of life. Journal of Asthma. 50(8). 891–899. 49 indexed citations

16.

Sheppard, Vanessa B., Claudine Isaacs, George Luta, et al.. (2013). Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient–provider relationship. Breast Cancer Research and Treatment. 139(1). 207–216. 52 indexed citations

17.

DeMarco, Tiffani A., Karen L. Smith, Rachel Nusbaum, et al.. (2007). Practical Aspects of Delivering Hereditary Cancer Risk Counseling. Seminars in Oncology. 34(5). 369–378. 23 indexed citations

18.

Kruger, Thinus F., et al.. (2001). Stepwise regression analysis to study male and female factors impacting on pregnancy rate in an intrauterine insemination programme. Andrologia. 33(3). 135–141. 60 indexed citations

19.

Coetzee, Kevin, F. S. H. Stander, Karen L. Smith, et al.. (1997). Effect of Sperm Preincubation Time on Gift Pregnancy Outcome. Archives of Andrology. 38(2). 157–161.

20.

Kruger, Thinus F., Roelof Menkveld, F. S. H. Stander, et al.. (1986). Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertility and Sterility. 46(6). 1118–1123. 993 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact